Verastem, (Germany) Top Insiders
| 2VSA Stock | 4.54 0.28 5.81% |
Verastem, employs about 78 people. The company is managed by 10 executives with a total tenure of roughly 182 years, averaging almost 18.0 years of service per executive, having 7.8 employees per reported executive. Examination of Verastem,'s management performance can provide insight into the company performance.
| Daniel Paterson CEO CEO President |
| Michael MD President President Director |
Verastem, |
Verastem, Management Team Effectiveness
The company has return on total asset (ROA) of (0.6606) % which means that it has lost $0.6606 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (28.8871) %, meaning that it generated substantial loss on money invested by shareholders. Verastem,'s management efficiency ratios could be used to measure how well Verastem, manages its routine affairs as well as how well it operates its assets and liabilities. The Verastem,'s current Return On Equity is estimated to increase to 5.46, while Return On Tangible Assets are forecasted to increase to (1.41). At this time, Verastem,'s Other Current Assets are most likely to increase significantly in the upcoming years. The Verastem,'s current Total Current Assets is estimated to increase to about 118.1 M, while Intangible Assets are projected to decrease to roughly 16.6 M.The Verastem,'s current Common Stock Shares Outstanding is estimated to increase to about 32.4 MVerastem, shows a total of 75.32 Million outstanding shares. The majority of Verastem, outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Verastem, to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Verastem,. Please pay attention to any change in the institutional holdings of Verastem as this could imply that something significant has changed or is about to change at the company. Also note that roughly one hundred thirty-five thousand five hundred seventy-six invesors are currently shorting Verastem, expressing very little confidence in its future performance.
Shares in Circulation | First Issued 2011-03-31 | Previous Quarter 74 M | Current Value 73.2 M | Avarage Shares Outstanding 10.6 M | Quarterly Volatility 14.5 M |
Verastem, Workforce Comparison
Verastem is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 318,610. Verastem, adds roughly 78.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
Verastem, Benchmark Summation
The output start index for this execution was one with a total number of output elements of sixty. The Lowest value over a specified period line plots minimum value of Verastem, price series.
Verastem, Notable Stakeholders
A Verastem, stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Verastem, often face trade-offs trying to please all of them. Verastem,'s stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Verastem,'s stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Robert Weinberg | CoFounder Board | Profile | |
| Michelle MD | CoFounder | Profile | |
| Daniel Paterson | CEO President | Profile | |
| Michael MD | President Director | Profile | |
| Jonathan Pachter | Chief Officer | Profile | |
| Mark Wanda | Senior Officer | Profile | |
| Daniel Calkins | Chief Officer | Profile | |
| Cathy Carew | Chief Officer | Profile | |
| Julissa Viana | Vice Relations | Profile | |
| Nate Sanburn | Chief Officer | Profile |
About Verastem, Management Performance
The success or failure of an entity such as Verastem, often depends on how effective the management is. Verastem, management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Verastem, management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Verastem, management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.48) | (1.41) | |
| Return On Capital Employed | (1.87) | (1.78) | |
| Return On Assets | (1.48) | (1.41) | |
| Return On Equity | 5.20 | 5.46 |
Verastem, Workforce Analysis
Traditionally, organizations such as Verastem, use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Verastem, within its industry.Verastem, Manpower Efficiency
Return on Verastem, Manpower
| Revenue Per Employee | 128.2K | |
| Revenue Per Executive | 1000K | |
| Net Loss Per Employee | 1.7M | |
| Net Loss Per Executive | 13.1M | |
| Working Capital Per Employee | 820.4K | |
| Working Capital Per Executive | 6.4M |
Complementary Tools for Verastem, Stock analysis
When running Verastem,'s price analysis, check to measure Verastem,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verastem, is operating at the current time. Most of Verastem,'s value examination focuses on studying past and present price action to predict the probability of Verastem,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verastem,'s price. Additionally, you may evaluate how the addition of Verastem, to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |